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Introduction
The mechanisms of persistent hyperlactemia during endo-
toxic shock are probably multifactorial. Both hypoperfu-
sion-related anaerobic production and adrenergic-driven
aerobic generation have been implicated. More recently
an early and severe impairment in exogenous lactate clear-
ance has also been described [1]. Theoretically, an exces-
sive adrenergic response could influence all these
mechanisms and thus aggravate the problem.
Objectives
To assess the effects of dexmedetomidine (DEX) on lactate
production and exogenous lactate clearance in an endo-
toxic shock model.
Methods
Twelve anesthetized sheep were subjected to a multimodal
hemodynamic/perfusion assessment including hepatic and
portal vein catheterizations, total hepatic blood flow, sub-
lingual microcirculation, and muscle microdialysis. After
the monitoring phase, all received a 5 mcg/kg LPS bolus
(E coli O127:B8®) and then 4 mcg·kg1·hr1 for the rest of
the experiment. After 1hr they were volume resuscitated,
and then randomized to placebo or DEX. Sampling and
exogenous lactate clearances [2] were performed at
4 points (figure 1).
Results
DEX was not associated with any adverse hemodynamic
effect in terms of cardiac output, heart rate, mixed venous
oxygen saturation, central venous-arterial pCO2 gradient
and NE requirements as compared to placebo. DEX
animals presented significant lower epinephrine levels (4.6
± 1.3 vs 7.1 ± 1.4 ng/ml), arterial lactate levels (6.4 ± 3.1 vs
9.2 ± 1.8 mmol/l), portal vein lactate levels (6.2 ± 2.2 vs 8.1
± 2.0 mmol/l); and higher portal vein O2 saturations (78 ±
16 vs 68 ± 11 %), and exogenous lactate clearance (7.2 ±
5.4 vs 2.9 ± 1.5 ml/kg/min) as compared to placebo at
point D. No differences in muscle lactate production or
sublingual microcirculatory parameters could be observed.
Conclusions
Dexmedetomidine ameliorates the increase in gut lactate
production and impairment of exogenous lactate clearance
in experimental endotoxic shock. This effect is associated
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